U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Search results

Items: 1 to 100 of 669

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr11:35685126-46981371
GRCh38:
Chr11:35663578-46959820
LOC130005622, LOC130005623, LOC130005624, LOC130005625, LOC130005626, LOC130005627, LOC130005628, LOC130005629, LOC130005630, LOC130005631, LOC130005632, LOC130005633, LOC130005634, LOC130005635, LOC130005636, LOC130005637, LOC130005638, LOC130005639, LOC130005640, LOC130005641, LOC130005642, LOC130005643, LOC130005644, LOC130005645, LOC130005646, LOC130005647, LOC130005648, LOC130005649, LOC130005650, LOC130005651, LOC130005652, LOC130005653, LOC130005654, LOC130005655, LOC130005656, LOC130005657, LOC130005658, LOC130005659, LOC130005660, LOC130005661, LOC130005662, LOC130005663, LOC130005664, LOC130005665, LOC132089932, LOC132089933, LOC132089934, LOC132089935, LOC132089936, LOC132089937, LOC132089938, LOC132089939, LOC132089940, LOC132090836, LOC132090837, LOC132090838, LRP4, LRP4-AS1, LRRC4C, MAPK8IP1, MDK, MIR129-2, MIR3160-1, MIR3160-2, MIR3973, MIR4688, MIR5582, MIR670, MIR670HG, MIR7154, PEX16, PHF21A, PRDM11, PRR5L, RAG1, RAG2, SLC35C1, SNORD67, SYT13, TP53I11, TRAF6, TRIM44, TSPAN18, TTC17, ZNF408, ACCS, ACCSL, ALKBH3, ALKBH3-AS1, ALX4, AMBRA1, API5, ARHGAP1, ATG13, C11orf96, CD82, CD82-AS1, CHRM4, CHST1, CKAP5, COMMD9, CREB3L1, CRY2, CSTPP1, DGKZ, EXT2, F2, FREY1, HARBI1, HSD17B12, IFTAP, LARGE2, LDLRAD3, LINC01493, LINC01499, LINC02489, LINC02685, LINC02687, LINC02690, LINC02696, LINC02704, LINC02710, LINC02716, LINC02740, LINC02741, LINC02745, LINC02759, LINC02760, LOC100507384, LOC101928510, LOC101928894, LOC105376635, LOC110121482, LOC112081394, LOC112081395, LOC112081396, LOC112081397, LOC113939922, LOC116216135, LOC116216136, LOC121392908, LOC121392909, LOC121392910, LOC121832790, LOC121832791, LOC124433245, LOC124433246, LOC124433247, LOC124433248, LOC124433249, LOC124433251, LOC124433252, LOC124433253, LOC124433254, LOC124433255, LOC124433256, LOC126861188, LOC126861189, LOC126861190, LOC126861191, LOC126861192, LOC126861193, LOC126861194, LOC126861195, LOC126861196, LOC126861197, LOC126861198, LOC126861199, LOC126861200, LOC126861201, LOC126861202, LOC126861203, LOC126861204, LOC129390280, LOC129390281, LOC130005571, LOC130005572, LOC130005573, LOC130005574, LOC130005575, LOC130005576, LOC130005577, LOC130005578, LOC130005579, LOC130005580, LOC130005581, LOC130005582, LOC130005583, LOC130005584, LOC130005585, LOC130005586, LOC130005587, LOC130005588, LOC130005589, LOC130005590, LOC130005591, LOC130005592, LOC130005593, LOC130005594, LOC130005595, LOC130005596, LOC130005597, LOC130005598, LOC130005599, LOC130005600, LOC130005601, LOC130005602, LOC130005603, LOC130005604, LOC130005605, LOC130005606, LOC130005607, LOC130005608, LOC130005609, LOC130005610, LOC130005611, LOC130005612, LOC130005613, LOC130005614, LOC130005615, LOC130005616, LOC130005617, LOC130005618, LOC130005619, LOC130005620, LOC130005621
See casesPathogenic
(Aug 12, 2011)
criteria provided, single submitter
2.
GRCh37:
Chr11:39200802-49157287
GRCh38:
Chr11:39179252-49135735
ACCS, ACCSL, ACP2, AGBL2, ALKBH3, ALKBH3-AS1, ALX4, AMBRA1, API5, ARFGAP2, ARHGAP1, ATG13, C11orf96, C1QTNF4, CD82, CD82-AS1, CELF1, CHRM4, CHST1, CKAP5, CREB3L1, CRY2, CSTPP1, DDB2, DGKZ, EXT2, F2, FAM180B, FNBP4, FREY1, HARBI1, HSD17B12, KBTBD4, LARGE2, LINC01499, LINC02489, LINC02685, LINC02687, LINC02690, LINC02696, LINC02704, LINC02710, LINC02716, LINC02740, LINC02741, LINC02745, LOC100507384, LOC101928894, LOC110121482, LOC111464990, LOC112081394, LOC112081395, LOC112081396, LOC112081397, LOC112081398, LOC112081399, LOC113939922, LOC113939923, LOC116216135, LOC116216136, LOC121392909, LOC121392910, LOC121392911, LOC121392912, LOC121392913, LOC121392914, LOC121832791, LOC124433248, LOC124433249, LOC124433251, LOC124433252, LOC124433253, LOC124433254, LOC124433255, LOC124433256, LOC124433257, LOC124433258, LOC126861195, LOC126861196, LOC126861197, LOC126861198, LOC126861199, LOC126861200, LOC126861201, LOC126861202, LOC126861203, LOC126861204, LOC126861205, LOC126861206, LOC129390281, LOC129390282, LOC129390283, LOC130005582, LOC130005583, LOC130005584, LOC130005585, LOC130005586, LOC130005587, LOC130005588, LOC130005589, LOC130005590, LOC130005591, LOC130005592, LOC130005593, LOC130005594, LOC130005595, LOC130005596, LOC130005597, LOC130005598, LOC130005599, LOC130005600, LOC130005601, LOC130005602, LOC130005603, LOC130005604, LOC130005605, LOC130005606, LOC130005607, LOC130005608, LOC130005609, LOC130005610, LOC130005611, LOC130005612, LOC130005613, LOC130005614, LOC130005615, LOC130005616, LOC130005617, LOC130005618, LOC130005619, LOC130005620, LOC130005621, LOC130005622, LOC130005623, LOC130005624, LOC130005625, LOC130005626, LOC130005627, LOC130005628, LOC130005629, LOC130005630, LOC130005631, LOC130005632, LOC130005633, LOC130005634, LOC130005635, LOC130005636, LOC130005637, LOC130005638, LOC130005639, LOC130005640, LOC130005641, LOC130005642, LOC130005643, LOC130005644, LOC130005645, LOC130005646, LOC130005647, LOC130005648, LOC130005649, LOC130005650, LOC130005651, LOC130005652, LOC130005653, LOC130005654, LOC130005655, LOC130005656, LOC130005657, LOC130005658, LOC130005659, LOC130005660, LOC130005661, LOC130005662, LOC130005663, LOC130005664, LOC130005665, LOC130005666, LOC130005667, LOC130005668, LOC130005669, LOC130005670, LOC130005671, LOC130005672, LOC130005673, LOC130005674, LOC130005675, LOC130005676, LOC130005677, LOC130005678, LOC130005679, LOC130005680, LOC130005681, LOC130005682, LOC130005683, LOC130005684, LOC130005685, LOC130005686, LOC130005687, LOC130005688, LOC130005689, LOC130005690, LOC130005691, LOC130005692, LOC130005693, LOC130005694, LOC130005695, LOC130005696, LOC130005697, LOC132089937, LOC132089938, LOC132089939, LOC132089940, LOC132090836, LOC132090837, LOC132090838, LRP4, LRP4-AS1, LRRC4C, MADD, MADD-AS1, MAPK8IP1, MDK, MIR129-2, MIR3160-1, MIR3160-2, MIR3161, MIR4487, MIR4688, MIR5582, MIR670, MIR670HG, MIR6745, MIR7154, MTCH2, MYBPC3, NDUFS3, NR1H3, NUP160, OR4A47, OR4B1, OR4C3, OR4C5, OR4S1, OR4X1, OR4X2, PACSIN3, PEX16, PHF21A, PRDM11, PSMC3, PTPMT1, PTPRJ, RAPSN, SLC35C1, SLC39A13, SLC39A13-AS1, SNORD67, SPI1, SYT13, TP53I11, TRIM49B, TRIM51G, TRIM64C, TSPAN18, TTC17, ZNF408
See casesPathogenic
(Apr 14, 2011)
no assertion criteria provided
3.
GRCh37:
Chr11:39706376-44866811
GRCh38:
Chr11:39684826-44845260
See casesPathogenic
(Aug 18, 2010)
no assertion criteria provided
4.
GRCh37:
Chr11:40710224-44205686
GRCh38:
Chr11:40688674-44184136
See casesLikely pathogenic
(Mar 9, 2012)
no assertion criteria provided
5.
GRCh37:
Chr11:40710224-44934960
GRCh38:
Chr11:40688674-44913409
See casesUncertain significance
(Feb 28, 2010)
no assertion criteria provided
6.
GRCh37:
Chr11:41139872-48664555
GRCh38:
Chr11:41118322-48643003
LOC130005585, LOC130005586, LOC130005587, LOC130005588, LOC130005589, LOC130005590, LOC130005591, LOC130005592, LOC130005593, LOC130005594, LOC130005595, LOC130005596, LOC130005597, LOC130005598, LOC130005599, LOC130005600, LOC130005601, LOC130005602, LOC130005603, LOC130005604, LOC130005605, LOC130005606, LOC130005607, LOC130005608, LOC130005609, LOC130005610, LOC130005611, LOC130005612, LOC130005613, LOC130005614, LOC130005615, LOC130005616, LOC130005617, LOC130005618, LOC130005619, LOC130005620, LOC130005621, LOC130005622, LOC130005623, LOC130005624, LOC130005625, LOC130005626, LOC130005627, LOC130005628, LOC130005629, LOC130005630, LOC130005631, LOC130005632, LOC130005633, LOC130005634, LOC130005635, LOC130005636, LOC130005637, LOC130005638, LOC130005639, LOC130005640, LOC130005641, LOC130005642, LOC130005643, LOC130005644, LOC130005645, LOC130005646, LOC130005647, LOC130005648, LOC130005649, LOC130005650, LOC130005651, LOC130005652, LOC130005653, LOC130005654, LOC130005655, LOC130005656, LOC130005657, LOC130005658, LOC130005659, LOC130005660, LOC130005661, LOC130005662, LOC130005663, LOC130005664, LOC130005665, LOC130005666, LOC130005667, LOC130005668, LOC130005669, LOC130005670, LOC130005671, LOC130005672, LOC130005673, LOC130005674, LOC130005675, LOC130005676, LOC130005677, LOC130005678, LOC130005679, LOC130005680, LOC130005681, LOC130005682, LOC130005683, LOC130005684, LOC130005685, LOC130005686, LOC130005687, LOC130005688, LOC130005689, LOC130005690, LOC130005691, LOC130005692, LOC130005693, LOC130005694, LOC130005695, LOC130005696, LOC130005697, LOC132089937, LOC132089938, LOC132089939, LOC132089940, LOC132090836, LOC132090837, LOC132090838, LRP4, LRP4-AS1, LRRC4C, MADD, MADD-AS1, MAPK8IP1, MDK, MIR129-2, MIR3160-1, MIR3160-2, MIR3161, MIR4487, MIR4688, MIR5582, MIR670, MIR670HG, MIR6745, MIR7154, MTCH2, MYBPC3, NDUFS3, NR1H3, NUP160, OR4A47, OR4B1, OR4C3, OR4C5, OR4S1, OR4X1, OR4X2, PACSIN3, PEX16, PHF21A, PRDM11, PSMC3, PTPMT1, PTPRJ, RAPSN, SLC35C1, SLC39A13, SLC39A13-AS1, SNORD67, SPI1, SYT13, TP53I11, TSPAN18, TTC17, ZNF408, ACCS, ACCSL, ACP2, AGBL2, ALKBH3, ALKBH3-AS1, ALX4, AMBRA1, API5, ARFGAP2, ARHGAP1, ATG13, C11orf96, C1QTNF4, CD82, CD82-AS1, CELF1, CHRM4, CHST1, CKAP5, CREB3L1, CRY2, CSTPP1, DDB2, DGKZ, EXT2, F2, FAM180B, FNBP4, FREY1, HARBI1, HSD17B12, KBTBD4, LARGE2, LINC01499, LINC02489, LINC02685, LINC02687, LINC02690, LINC02696, LINC02704, LINC02710, LINC02716, LINC02740, LINC02741, LINC02745, LOC100507384, LOC101928894, LOC110121482, LOC111464990, LOC112081394, LOC112081395, LOC112081396, LOC112081397, LOC112081398, LOC112081399, LOC113939922, LOC113939923, LOC116216135, LOC116216136, LOC121392909, LOC121392910, LOC121392911, LOC121392912, LOC121392913, LOC121392914, LOC121832791, LOC124433249, LOC124433251, LOC124433252, LOC124433253, LOC124433254, LOC124433255, LOC124433256, LOC124433257, LOC124433258, LOC126861197, LOC126861198, LOC126861199, LOC126861200, LOC126861201, LOC126861202, LOC126861203, LOC126861204, LOC126861205, LOC126861206, LOC129390281, LOC129390282, LOC129390283, LOC130005582, LOC130005583, LOC130005584
See casesPathogenic
(Jul 30, 2009)
no assertion criteria provided
7.
GRCh37:
Chr11:42575209-46136343
GRCh38:
Chr11:42553659-46114792
See casesPathogenic
(Mar 10, 2014)
no assertion criteria provided
8.
GRCh37:
Chr11:42749105-49157287
GRCh38:
Chr11:42727555-49135735
ACCS, ACCSL, ACP2, AGBL2, ALKBH3, ALKBH3-AS1, ALX4, AMBRA1, API5, ARFGAP2, ARHGAP1, ATG13, C11orf96, C1QTNF4, CD82, CD82-AS1, CELF1, CHRM4, CHST1, CKAP5, CREB3L1, CRY2, CSTPP1, DDB2, DGKZ, EXT2, F2, FAM180B, FNBP4, FREY1, HARBI1, HSD17B12, KBTBD4, LARGE2, LINC02489, LINC02685, LINC02687, LINC02690, LINC02696, LINC02704, LINC02710, LINC02716, LOC100507384, LOC101928894, LOC110121482, LOC111464990, LOC112081394, LOC112081395, LOC112081396, LOC112081397, LOC112081398, LOC112081399, LOC113939922, LOC113939923, LOC116216135, LOC116216136, LOC121392909, LOC121392910, LOC121392911, LOC121392912, LOC121392913, LOC121392914, LOC121832791, LOC124433249, LOC124433251, LOC124433252, LOC124433253, LOC124433254, LOC124433255, LOC124433256, LOC124433257, LOC124433258, LOC126861199, LOC126861200, LOC126861201, LOC126861202, LOC126861203, LOC126861204, LOC126861205, LOC126861206, LOC129390281, LOC129390282, LOC129390283, LOC130005582, LOC130005583, LOC130005584, LOC130005585, LOC130005586, LOC130005587, LOC130005588, LOC130005589, LOC130005590, LOC130005591, LOC130005592, LOC130005593, LOC130005594, LOC130005595, LOC130005596, LOC130005597, LOC130005598, LOC130005599, LOC130005600, LOC130005601, LOC130005602, LOC130005603, LOC130005604, LOC130005605, LOC130005606, LOC130005607, LOC130005608, LOC130005609, LOC130005610, LOC130005611, LOC130005612, LOC130005613, LOC130005614, LOC130005615, LOC130005616, LOC130005617, LOC130005618, LOC130005619, LOC130005620, LOC130005621, LOC130005622, LOC130005623, LOC130005624, LOC130005625, LOC130005626, LOC130005627, LOC130005628, LOC130005629, LOC130005630, LOC130005631, LOC130005632, LOC130005633, LOC130005634, LOC130005635, LOC130005636, LOC130005637, LOC130005638, LOC130005639, LOC130005640, LOC130005641, LOC130005642, LOC130005643, LOC130005644, LOC130005645, LOC130005646, LOC130005647, LOC130005648, LOC130005649, LOC130005650, LOC130005651, LOC130005652, LOC130005653, LOC130005654, LOC130005655, LOC130005656, LOC130005657, LOC130005658, LOC130005659, LOC130005660, LOC130005661, LOC130005662, LOC130005663, LOC130005664, LOC130005665, LOC130005666, LOC130005667, LOC130005668, LOC130005669, LOC130005670, LOC130005671, LOC130005672, LOC130005673, LOC130005674, LOC130005675, LOC130005676, LOC130005677, LOC130005678, LOC130005679, LOC130005680, LOC130005681, LOC130005682, LOC130005683, LOC130005684, LOC130005685, LOC130005686, LOC130005687, LOC130005688, LOC130005689, LOC130005690, LOC130005691, LOC130005692, LOC130005693, LOC130005694, LOC130005695, LOC130005696, LOC130005697, LOC132089937, LOC132089938, LOC132089939, LOC132089940, LOC132090836, LOC132090837, LOC132090838, LRP4, LRP4-AS1, MADD, MADD-AS1, MAPK8IP1, MDK, MIR129-2, MIR3160-1, MIR3160-2, MIR3161, MIR4487, MIR4688, MIR5582, MIR670, MIR670HG, MIR6745, MIR7154, MTCH2, MYBPC3, NDUFS3, NR1H3, NUP160, OR4A47, OR4B1, OR4C3, OR4C5, OR4S1, OR4X1, OR4X2, PACSIN3, PEX16, PHF21A, PRDM11, PSMC3, PTPMT1, PTPRJ, RAPSN, SLC35C1, SLC39A13, SLC39A13-AS1, SNORD67, SPI1, SYT13, TP53I11, TRIM49B, TRIM51G, TRIM64C, TSPAN18, TTC17, ZNF408
See casesLikely pathogenic
(Aug 2, 2012)
no assertion criteria provided
9.
GRCh38:
Chr11:42871836-44852545
not specifiedUncertain significance
(Sep 28, 2022)
criteria provided, single submitter
10.
GRCh37:
Chr11:44117102
GRCh38:
Chr11:44095552
EXT2, LOC130005598Exostoses, multiple, type 2Benign
(Jan 12, 2018)
criteria provided, single submitter
11.
GRCh37:
Chr11:44117122
GRCh38:
Chr11:44095572
EXT2, LOC130005598Exostoses, multiple, type 2Benign
(Jan 12, 2018)
criteria provided, single submitter
12.
GRCh37:
Chr11:44117126
GRCh38:
Chr11:44095576
EXT2, LOC130005598Exostoses, multiple, type 2Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
13.
GRCh37:
Chr11:44117191
GRCh38:
Chr11:44095641
EXT2, LOC130005598Exostoses, multiple, type 2Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
14.
GRCh37:
Chr11:44117236
GRCh38:
Chr11:44095686
EXT2, LOC130005598Exostoses, multiple, type 2Benign
(Jan 13, 2018)
criteria provided, single submitter
15.
GRCh37:
Chr11:44117285
GRCh38:
Chr11:44095735
EXT2, LOC130005598Exostoses, multiple, type 2Benign
(Jan 13, 2018)
criteria provided, single submitter
16.
GRCh37:
Chr11:44117372
GRCh38:
Chr11:44095822
LOC130005598, EXT2Exostoses, multiple, type 2Benign
(Jan 13, 2018)
criteria provided, single submitter
17.
GRCh37:
Chr11:44117388
GRCh38:
Chr11:44095838
EXT2, LOC130005598Exostoses, multiple, type 2Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
18.
GRCh37:
Chr11:44117409
GRCh38:
Chr11:44095859
EXT2, LOC130005598Exostoses, multiple, type 2, not specified, not provided
Benign
(Jun 25, 2020)
criteria provided, multiple submitters, no conflicts
19.
GRCh37:
Chr11:44117424
GRCh38:
Chr11:44095874
EXT2, LOC130005598not providedBenign
(Jul 27, 2018)
criteria provided, single submitter
20.
GRCh37:
Chr11:44117444
GRCh38:
Chr11:44095894
EXT2, LOC130005598not providedBenign
(Jul 27, 2018)
criteria provided, single submitter
21.
GRCh37:
Chr11:44117508
GRCh38:
Chr11:44095958
EXT2, LOC130005598not providedLikely benign
(May 12, 2021)
criteria provided, single submitter
22.
GRCh37:
Chr11:44117855
GRCh38:
Chr11:44096305
EXT2Q18RExostoses, multiple, type 2Uncertain significance
(May 23, 2022)
criteria provided, single submitter
23.
GRCh37:
Chr11:44117867
GRCh38:
Chr11:44096317
EXT2D22GOvarian cancerBenign
(Jan 1, 2022)
criteria provided, single submitter
24.
GRCh37:
Chr11:44117876
GRCh38:
Chr11:44096326
EXT2not providedLikely benign
(Sep 6, 2019)
criteria provided, single submitter
25.
GRCh37:
Chr11:44117898
GRCh38:
Chr11:44096348
EXT2not providedBenign
(Jul 27, 2018)
criteria provided, single submitter
26.
GRCh37:
Chr11:44118059
GRCh38:
Chr11:44096509
EXT2not providedLikely benign
(Jan 5, 2021)
criteria provided, single submitter
27.
GRCh37:
Chr11:44129086
GRCh38:
Chr11:44107536
EXT2not providedBenign
(Jul 27, 2018)
criteria provided, single submitter
28.
GRCh37:
Chr11:44129153
GRCh38:
Chr11:44107603
EXT2not providedLikely benign
(Jan 22, 2021)
criteria provided, single submitter
29.
GRCh37:
Chr11:44129213-44151708
GRCh38:
Chr11:44107663-44130158
EXT2, LOC130005600, LOC130005601Exostoses, multiple, type 2Pathogenic
(Feb 21, 2018)
criteria provided, single submitter
30.
GRCh37:
Chr11:44129223
GRCh38:
Chr11:44107673
EXT2Multiple congenital exostosisUncertain significance
(Mar 17, 2022)
criteria provided, single submitter
31.
GRCh37:
Chr11:44129237
GRCh38:
Chr11:44107687
EXT2C25FExostoses, multiple, type 2Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
32.
GRCh37:
Chr11:44129270
GRCh38:
Chr11:44107720
EXT2A3V, A36VExostoses, multiple, type 2Likely benign
(Oct 26, 2022)
criteria provided, multiple submitters, no conflicts
33.
GRCh37:
Chr11:44129271
GRCh38:
Chr11:44107721
EXT2Exostoses, multiple, type 2Likely benign
(Aug 12, 2021)
criteria provided, single submitter
34.
GRCh37:
Chr11:44129273
GRCh38:
Chr11:44107723
EXT2S37L, S4LSeizures-scoliosis-macrocephaly syndrome, Exostoses, multiple, type 2Conflicting interpretations of pathogenicity
(Oct 5, 2022)
criteria provided, conflicting interpretations
35.
GRCh37:
Chr11:44129280
GRCh38:
Chr11:44107730
EXT2Exostoses, multiple, type 2Likely benign
(Jun 1, 2021)
criteria provided, single submitter
36.
GRCh37:
Chr11:44129290
GRCh38:
Chr11:44107740
EXT2R10W, R43WExostoses, multiple, type 2Uncertain significance
(Sep 1, 2022)
criteria provided, single submitter
37.
GRCh37:
Chr11:44129290
GRCh38:
Chr11:44107740
EXT2Exostoses, multiple, type 1, not specified, not provided,
Exostoses, multiple, type 2
Benign
(Jul 7, 2023)
criteria provided, multiple submitters, no conflicts
38.
GRCh37:
Chr11:44129293
GRCh38:
Chr11:44107743
EXT2G44S, G11SExostoses, multiple, type 2Uncertain significance
(Oct 7, 2022)
criteria provided, multiple submitters, no conflicts
39.
GRCh37:
Chr11:44129299
GRCh38:
Chr11:44107749
EXT2A13T, A46TExostoses, multiple, type 2Uncertain significance
(Sep 1, 2021)
criteria provided, single submitter
40.
GRCh37:
Chr11:44129312
GRCh38:
Chr11:44107762
EXT2R50K, R17KExostoses, multiple, type 2Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
41.
GRCh37:
Chr11:44129317
GRCh38:
Chr11:44107767
EXT2K52fs, K19fsnot providedPathogenic
(Mar 16, 2017)
criteria provided, single submitter
42.
GRCh37:
Chr11:44129323
GRCh38:
Chr11:44107773
EXT2K21E, K54EExostoses, multiple, type 2Uncertain significance
(Nov 23, 2021)
criteria provided, single submitter
43.
GRCh37:
Chr11:44129325-44129329
GRCh38:
Chr11:44107775-44107779
EXT2H22fs, H55fsExostoses, multiple, type 2Pathogenic
(Aug 31, 2021)
criteria provided, single submitter
44.
GRCh37:
Chr11:44129327
GRCh38:
Chr11:44107777
EXT2H22R, H55RExostoses, multiple, type 2Uncertain significance
(Aug 31, 2021)
criteria provided, single submitter
45.
GRCh37:
Chr11:44129329
GRCh38:
Chr11:44107779
EXT2R23*, R56*not provided, Exostoses, multiple, type 2Pathogenic
(Oct 17, 2022)
criteria provided, multiple submitters, no conflicts
46.
GRCh37:
Chr11:44129330
GRCh38:
Chr11:44107780
EXT2R23Q, R56QInborn genetic diseasesUncertain significance
(May 24, 2023)
criteria provided, single submitter
47.
GRCh37:
Chr11:44129331
GRCh38:
Chr11:44107781
EXT2Exostoses, multiple, type 2Uncertain significance
(Jan 28, 2022)
criteria provided, single submitter
48.
GRCh37:
Chr11:44129346
GRCh38:
Chr11:44107796
EXT2Exostoses, multiple, type 2Likely benign
(Sep 10, 2022)
criteria provided, single submitter
49.
GRCh37:
Chr11:44129346
GRCh38:
Chr11:44107796
EXT2Exostoses, multiple, type 2Likely benign
(Sep 1, 2022)
criteria provided, single submitter
50.
GRCh37:
Chr11:44129347-44129348
GRCh38:
Chr11:44107797-44107798
EXT2F30fs, F63fsnot providedPathogenic
(Aug 22, 2016)
criteria provided, single submitter
51.
GRCh37:
Chr11:44129350
GRCh38:
Chr11:44107800
EXT2F30fs, F63fsExostoses, multiple, type 2Pathogenic
(Apr 5, 2021)
criteria provided, single submitter
52.
GRCh37:
Chr11:44129354
GRCh38:
Chr11:44107804
EXT2I32fs, I65fsnot providedLikely pathogenic
(May 6, 2022)
criteria provided, single submitter
53.
GRCh37:
Chr11:44129355
GRCh38:
Chr11:44107805
EXT2Exostoses, multiple, type 2Likely benign
(Oct 13, 2022)
criteria provided, single submitter
54.
GRCh37:
Chr11:44129356
GRCh38:
Chr11:44107806
EXT2I65V, I32VExostoses, multiple, type 2Uncertain significance
(Aug 16, 2022)
criteria provided, single submitter
55.
GRCh37:
Chr11:44129379
GRCh38:
Chr11:44107829
EXT2Exostoses, multiple, type 2Likely benign
(Aug 28, 2020)
criteria provided, single submitter
56.
GRCh37:
Chr11:44129386
GRCh38:
Chr11:44107836
EXT2M42V, M75VExostoses, multiple, type 1, not specified, not provided,
Exostoses, multiple, type 2
Benign/Likely benign
(Jul 7, 2023)
criteria provided, multiple submitters, no conflicts
57.
GRCh37:
Chr11:44129391-44129392
GRCh38:
Chr11:44107841-44107842
EXT2Exostoses, multiple, type 2Pathogenic
(Apr 1, 2019)
criteria provided, single submitter
58.
GRCh37:
Chr11:44129405
GRCh38:
Chr11:44107855
EXT2H81L, H48Lnot providedBenign
(Oct 3, 2017)
criteria provided, single submitter
59.
GRCh37:
Chr11:44129409
GRCh38:
Chr11:44107859
EXT2Exostoses, multiple, type 2Likely benign
(Aug 29, 2022)
criteria provided, single submitter
60.
GRCh37:
Chr11:44129412
GRCh38:
Chr11:44107862
EXT2Exostoses, multiple, type 2Benign
(Jun 20, 2022)
criteria provided, single submitter
61.
GRCh37:
Chr11:44129413
GRCh38:
Chr11:44107863
EXT2E51K, E84KExostoses, multiple, type 2Uncertain significance
(Apr 27, 2017)
criteria provided, single submitter
62.
GRCh37:
Chr11:44129418
GRCh38:
Chr11:44107868
EXT2not specifiedLikely benign
(Feb 21, 2022)
criteria provided, single submitter
63.
GRCh37:
Chr11:44129430
GRCh38:
Chr11:44107880
EXT2W56*, W89*Exostoses, multiple, type 2Likely pathogenic
(Sep 30, 2022)
criteria provided, single submitter
64.
GRCh37:
Chr11:44129444
GRCh38:
Chr11:44107894
EXT2R61H, R94HExostoses, multiple, type 2Likely benign
(Oct 8, 2022)
criteria provided, single submitter
65.
GRCh37:
Chr11:44129454
GRCh38:
Chr11:44107904
EXT2Exostoses, multiple, type 2Likely benign
(Oct 5, 2021)
criteria provided, single submitter
66.
GRCh37:
Chr11:44129460
GRCh38:
Chr11:44107910
EXT2Exostoses, multiple, type 2Conflicting interpretations of pathogenicity
(Jun 22, 2022)
criteria provided, conflicting interpretations
67.
GRCh37:
Chr11:44129462
GRCh38:
Chr11:44107912
EXT2P100L, P67LExostoses, multiple, type 2, Inborn genetic diseasesUncertain significance
(Jun 29, 2023)
criteria provided, multiple submitters, no conflicts
68.
GRCh37:
Chr11:44129463
GRCh38:
Chr11:44107913
EXT2Exostoses, multiple, type 2Benign
(Oct 5, 2022)
criteria provided, multiple submitters, no conflicts
69.
GRCh37:
Chr11:44129465-44129520
GRCh38:
Chr11:44107915-44107970
EXT2V68fs, V101fsExostoses, multiple, type 2Pathogenic
(Sep 1, 2021)
criteria provided, single submitter
70.
GRCh37:
Chr11:44129467
GRCh38:
Chr11:44107917
EXT2V102I, V69IExostoses, multiple, type 2Uncertain significance
(Aug 28, 2021)
criteria provided, multiple submitters, no conflicts
71.
GRCh37:
Chr11:44129472
GRCh38:
Chr11:44107922
EXT2Exostoses, multiple, type 2Likely benign
(May 7, 2022)
criteria provided, single submitter
72.
GRCh37:
Chr11:44129473
GRCh38:
Chr11:44107923
EXT2Exostoses, multiple, type 2Likely benign
(Dec 1, 2020)
criteria provided, single submitter
73.
GRCh37:
Chr11:44129473
GRCh38:
Chr11:44107923
EXT2L71fs, L104fsExostoses, multiple, type 2Pathogenic
(Dec 19, 2019)
criteria provided, single submitter
74.
GRCh37:
Chr11:44129481
GRCh38:
Chr11:44107931
EXT2Exostoses, multiple, type 2Likely benign
(Oct 17, 2021)
criteria provided, single submitter
75.
GRCh37:
Chr11:44129488
GRCh38:
Chr11:44107938
EXT2P109T, P76TExostoses, multiple, type 2Uncertain significance
(Dec 31, 2021)
criteria provided, single submitter
76.
GRCh37:
Chr11:44129494
GRCh38:
Chr11:44107944
EXT2P111A, P78Anot specifiednot provided
(Sep 19, 2013)
no assertion provided
77.
GRCh37:
Chr11:44129498
GRCh38:
Chr11:44107948
EXT2E112G, E79GExostoses, multiple, type 2Uncertain significance
(May 13, 2022)
criteria provided, single submitter
78.
GRCh37:
Chr11:44129500-44129501
GRCh38:
Chr11:44107950-44107951
EXT2D115fs, D82fsExostoses, multiple, type 2Pathogenic
(Nov 2, 2021)
criteria provided, single submitter
79.
GRCh37:
Chr11:44129500
GRCh38:
Chr11:44107950
EXT2R113W, R80WExostoses, multiple, type 2Uncertain significance
(Sep 19, 2022)
criteria provided, single submitter
80.
GRCh37:
Chr11:44129500
GRCh38:
Chr11:44107950
EXT2R113fs, R80fsExostoses, multiple, type 2Likely pathogenic
(Aug 24, 2017)
criteria provided, single submitter
81.
GRCh37:
Chr11:44129501
GRCh38:
Chr11:44107951
EXT2R80Q, R113QExostoses, multiple, type 2Uncertain significance
(Oct 29, 2021)
criteria provided, single submitter
82.
GRCh37:
Chr11:44129501
GRCh38:
Chr11:44107951
EXT2D115fs, D82fsExostoses, multiple, type 2Pathogenic
(Apr 4, 2022)
criteria provided, single submitter
83.
GRCh37:
Chr11:44129506-44129507
GRCh38:
Chr11:44107956-44107957
EXT2D115fs, D82fsExostoses, multiple, type 2, not providedPathogenic
(Dec 20, 2018)
criteria provided, multiple submitters, no conflicts
84.
GRCh37:
Chr11:44129507
GRCh38:
Chr11:44107957
EXT2D115A, D82AExostoses, multiple, type 2Conflicting interpretations of pathogenicity
(Aug 27, 2021)
criteria provided, conflicting interpretations
85.
GRCh37:
Chr11:44129508-44129509
GRCh38:
Chr11:44107958-44107959
EXT2L83fs, L116fsExostoses, multiple, type 2Pathogenic
(Jun 9, 2022)
criteria provided, single submitter
86.
GRCh37:
Chr11:44129508
GRCh38:
Chr11:44107958
EXT2Exostoses, multiple, type 2Likely benign
(Apr 16, 2020)
criteria provided, single submitter
87.
GRCh37:
Chr11:44129514
GRCh38:
Chr11:44107964
EXT2Exostoses, multiple, type 2Likely benign
(Oct 1, 2021)
criteria provided, single submitter
88.
GRCh37:
Chr11:44129515-44129521
GRCh38:
Chr11:44107965-44107971
EXT2R119fs, R86fsExostoses, multiple, type 2Pathogenic
(Sep 1, 2021)
criteria provided, single submitter
89.
GRCh37:
Chr11:44129522
Chr11:44129545
GRCh38:
Chr11:44107972
Chr11:44107995
EXT2, EXT2M120R, M87R, R95C, R128CSeizures-scoliosis-macrocephaly syndromePathogenic
(Oct 1, 2015)
no assertion criteria provided
90.
GRCh37:
Chr11:44129522
GRCh38:
Chr11:44107972
EXT2M120R, M87Rnot provided, Exostoses, multiple, type 2Conflicting interpretations of pathogenicity
(Oct 5, 2022)
criteria provided, conflicting interpretations
91.
GRCh37:
Chr11:44129523
GRCh38:
Chr11:44107973
EXT2M120I, M87IExostoses, multiple, type 2Uncertain significance
(Aug 30, 2021)
criteria provided, single submitter
92.
GRCh37:
Chr11:44129526
GRCh38:
Chr11:44107976
EXT2Exostoses, multiple, type 1, not specified, Exostoses, multiple, type 2
Benign
(Jul 7, 2023)
criteria provided, multiple submitters, no conflicts
93.
GRCh37:
Chr11:44129528
GRCh38:
Chr11:44107978
EXT2T89M, T122MExostoses, multiple, type 2Uncertain significance
(Oct 4, 2022)
criteria provided, single submitter
94.
GRCh37:
Chr11:44129529
GRCh38:
Chr11:44107979
EXT2Exostoses, multiple, type 2Likely benign
(Jun 24, 2020)
criteria provided, single submitter
95.
GRCh37:
Chr11:44129544
GRCh38:
Chr11:44107994
EXT2Y127*, Y94*Exostoses, multiple, type 2Pathogenic
(Oct 22, 2021)
criteria provided, single submitter
96.
GRCh37:
Chr11:44129545
GRCh38:
Chr11:44107995
EXT2R95C, R128CExostoses, multiple, type 2Uncertain significance
(Aug 28, 2022)
criteria provided, single submitter
97.
GRCh37:
Chr11:44129546
GRCh38:
Chr11:44107996
EXT2R128H, R95Hnot provided, Exostoses, multiple, type 2Conflicting interpretations of pathogenicity
(Oct 24, 2022)
criteria provided, conflicting interpretations
98.
GRCh37:
Chr11:44129558
GRCh38:
Chr11:44108008
EXT2N132I, N99IExostoses, multiple, type 2Uncertain significance
(May 3, 2022)
criteria provided, single submitter
99.
GRCh37:
Chr11:44129568
GRCh38:
Chr11:44108018
EXT2Exostoses, multiple, type 2Likely benign
(Jun 30, 2020)
criteria provided, single submitter
100.
GRCh37:
Chr11:44129569
GRCh38:
Chr11:44108019
EXT2K103E, K136Enot providedUncertain significance
(Nov 3, 2021)
criteria provided, single submitter
Format
Items per page
Sort by
Choose Destination